Compagnie Lombard Odier S Cm A Lexicon Pharmaceuticals, Inc. Transaction History
Compagnie Lombard Odier S Cm A
- $8.71 Billion
- Q3 2025
A detailed history of Compagnie Lombard Odier S Cm A transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 410,000 shares of LXRX stock, worth $582,200. This represents 0.01% of its overall portfolio holdings.
Number of Shares
410,000
Previous 330,000
24.24%
Holding current value
$582,200
Previous $313,000
80.51%
% of portfolio
0.01%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding LXRX
# of Institutions
135Shares Held
227MCall Options Held
2.5MPut Options Held
271K-
Artal Group S.A. Luxembourg, N4136MShares$193 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$55.3 Million2.06% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.52MShares$13.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.83MShares$5.44 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $268M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...